Detalles de la búsqueda
1.
Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021.
Clin Genitourin Cancer
; 22(3): 102047, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430859
2.
Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis.
Clin Transl Oncol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421563
3.
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
JCO Precis Oncol
; 7: e2200258, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716415
4.
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.
Biomolecules
; 12(6)2022 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740909
5.
Management of advanced ovarian cancer in Spain: an expert Delphi consensus.
J Ovarian Res
; 14(1): 72, 2021 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039386
6.
Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
Cancer Chemother Pharmacol
; 73(4): 857-67, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24570330
Resultados
1 -
6
de 6
1
Próxima >
>>